1 year return (CAGR)
-4.45%
SAB Biotherapeutics Inc Exchange (NASDAQ, USD)
SABS
2.79
-0.05 (-1.76%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-29.55%
5 year return (CAGR)
-51.57%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
253.85M
Price/Sales
-
Ent value
269.01M
Price/Book
1.18
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-45.80%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.91 |
| Daily high | 2.94 |
| Daily low | 2.77 |
| Daily Volume | 324K |
| All-time high | 112.40 |
| 1y analyst estimate | 11.64 |
| Beta | 0.54 |
| EPS (TTM) | -0.16 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SABS | S&P500 | |
| Current price drop from All-time high | -97.52% | -1.76% |
| Highest price drop | -99.01% | -56.47% |
| Date of highest drop | 7 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -79.29% | -10.65% |
| Avg time to new high | 179 days | 12 days |
| Max time to new high | 1230 days | 1805 days |
News
